Cargando…
Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study
A blood-based biomarker to complement the clinical and neuropsychological assessments used to evaluate the risk of individuals with mild cognitive impairment (MCI) developing Alzheimer’s disease (AD) would be invaluable. Previous pilot studies by our group identified elevated platelet membrane β-sec...
Autores principales: | McGuinness, Bernadette, Fuchs, Marc, Barrett, Suzanne L., Passmore, A. Peter, Johnston, Janet A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927817/ https://www.ncbi.nlm.nih.gov/pubmed/26639974 http://dx.doi.org/10.3233/JAD-150795 |
Ejemplares similares
-
Predicting conversion to dementia in a memory clinic: A standard clinical approach compared with an empirically defined clustering method (latent profile analysis) for mild cognitive impairment subtyping
por: McGuinness, Bernadette, et al.
Publicado: (2015) -
Untargeted Metabolomic Analysis of Human Plasma Indicates Differentially Affected Polyamine and L-Arginine Metabolism in Mild Cognitive Impairment Subjects Converting to Alzheimer’s Disease
por: Graham, Stewart F., et al.
Publicado: (2015) -
Dementia
por: Cunningham, EL, et al.
Publicado: (2015) -
Living alone for people on dementia medication: related use of drugs
por: Zafeiridi, Evi, et al.
Publicado: (2020) -
Factors influencing transition to care homes for people with dementia in Northern Ireland
por: Zafeiridi, Evi, et al.
Publicado: (2021)